期刊文献+

聚乙二醇-牛血红蛋白停搏液对离体心脏功能和超微结构的影响

Effect of Polyethylene Glycol-Bovine Hemoglobin Cardioplegic Solution on Cardiac Function in Vitro
下载PDF
导出
摘要 目的观察含聚乙二醇-牛血红蛋白(polyethylene glycol-bovine hemoglobin,PEG-bHb)的心脏停搏液对离体心脏功能的影响。方法32只成年雄性S-D大鼠根据停搏液不同随机分为4组,麻醉后开胸取心,建立Langendorff离体心脏灌注模型,平衡20 min后灌注冷St.Thomas液或三种不同浓度的PEG-bHb停搏液,30℃保持60 min后恢复灌注。记录各组左室发展压(LVDP)、左心室内压最大变化速率(±dp/dtmax)和冠脉流出量(CF)等血流动力学指标,并行超微结构观察。结果恢复灌注后,三个PEG-bHb组的LDVP、±dp/dtmax及CF均显著高于St.Thomas液组(P<0.05),超微结构也得到较好的保护。三个PEG-bHb组之间除CF外,其余指标均无明显差异(P>0.05)。结论以PEG-bHb制成的含血停搏液可以改善离体心脏的血流动力学表现和超微结构。 OBJECTIVE To evaluate the effect of polyethylene glycol-bovine hemoglobin(PEG-bHb)-containing cardioplegic solution on cardiac function in isolated animal hearts.METHODS The hearts of 32 male S-D rats were harvested and transferred to langendorff circuit.They were divided into 4 groups according to cardioplegia: St.Thomas or 3 different concentrations of PEG-bHb in St.Thomas solution.After 20 min balance period,hearts were perfused with cold(4℃) cardioplegic solutions,and preserved at 30℃ for 60 min,then reperfused.RESULTS After reperfusion,left ventricular developed pressure(LVDP),derivative of pressure(±dp/dtmax) and coronary flow(CF) were higher in PEG-bHb groups(P〈0.05).Ultrastructures were better preserved in PEG-bHb groups.There was no difference among 3 PEG-bHb groups except CF.CONCLUSION PEG-bHb in cardioplegic solutions can improve hemodynamic values and ultrastrctures in hearts after ischemia.
出处 《中国体外循环杂志》 2008年第2期100-103,共4页 Chinese Journal of Extracorporeal Circulation
关键词 聚乙二醇-牛血红蛋白 停搏液 心脏功能 血流动力学 超微结构 Polyethylene glycol-bovine hemoglobin Cardioplegic solution Myocardial function Hemodynamics Ultrastructure
  • 相关文献

参考文献8

  • 1[1]Follette DM,Steed DL,Faglia R,et al.Advantages of intermittent blood cardioplegia over intermittent ischemia during prolonged hypothermic aortic clamping[J].Circulation,1978,58(3 Pt 2):1200-1209.
  • 2[2]Anbari KK,Garino JP,Mackenzie CF.Hemoglobin substitutes[J].Eur Spine J,2004,13(Suppll):S76-82.
  • 3[3]Ibrahim MF,Venn GE,Young CP,et al.A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution[J].Eur J Cardiothorac Surg,1999,15(1):75-83.
  • 4[4]Barner HB.Blood cardioplegia:a review and comparison with crystalloid cardioplegia[J].Ann Thoarc Surg 1991,52(6):1354-1367.
  • 5[5]Spahn DR,Kocian R.Artificial O2 carriers:status in 2005[J].Curr Pharm Des,2005,11(31):4099-4114.
  • 6侯继锋,叶苗.聚乙二醇修饰的牛血红蛋白血液代用品抗原性和免疫原性的研究[J].中国生化药物杂志,2005,26(1):29-31. 被引量:5
  • 7[7]Carlucci F,Miraldi F,Barretta A,et al.Preservation of myocardial energy status by bovine hemoglobin solutions during ischemia[J].Biomed Pharmacother,2002,56(5):247-253.
  • 8[8]Serna DL,Powell LL,Kahwaji C,et al.Cardiac function after eight hour storage by using polyethylene glycol hemoglobin versus crystalloid perfusion[J].ASAIO J,2000,46(5):547-552.

二级参考文献2

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部